Mainolfi Nelloinsider trades
In SEC Form 4 filings, Mainolfi Nello is listed as Chief Executive Officer of Kymera Therapeutics, Inc. (KYMR). In the last 90 days, Mainolfi Nello sold $3.41M of Kymera Therapeutics, Inc. (KYMR) on the open market and bought none. All 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| KYMRKymera Therapeutics, Inc. | Chief Executive Officer | 8 | Oct 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | M | 30,000 | $2.08 | $62,400 | 696,568 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 3,525 | $111.44 | Sale −$392,826 | 693,043 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 5,506 | $112.42 | Sale −$618,985 | 687,537 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 4,876 | $113.24 | Sale −$552,158 | 682,661 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 7,601 | $114.43 | Sale −$869,782 | 675,060 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 8,230 | $115.40 | Sale −$949,742 | 666,830 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | S | 262 | $116.12 | Sale −$30,423 | 666,568 | Yes | Form 4 |
| KYMRKymera Therapeutics, Inc. | Oct 1 | Oct 1 | M · derivative | 30,000 | $2.08 | $62,400 | 60,000 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.